Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Prediction of Drug Efficacy in Colon Cancer Preclinical Models Using a Novel Ranking Method of Gene Expression.

Fritz J, Lefebvre O, Fernandez A, Schmidt J, Bagnard D.

Cancers (Basel). 2020 Jan 8;12(1). pii: E149. doi: 10.3390/cancers12010149.

2.

Functionalized Tobacco Mosaic Virus Coat Protein Monomers and Oligomers as Nanocarriers for Anti-Cancer Peptides.

Gamper C, Spenlé C, Boscá S, van der Heyden M, Erhardt M, Orend G, Bagnard D, Heinlein M.

Cancers (Basel). 2019 Oct 22;11(10). pii: E1609. doi: 10.3390/cancers11101609.

3.

Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination.

Binamé F, Pham-Van LD, Spenlé C, Jolivel V, Birmpili D, Meyer LA, Jacob L, Meyer L, Mensah-Nyagan AG, Po C, Van der Heyden M, Roussel G, Bagnard D.

EMBO Mol Med. 2019 Nov 7;11(11):e10378. doi: 10.15252/emmm.201910378. Epub 2019 Sep 30.

4.

Semaphorin 3A receptor inhibitor as a novel therapeutic to promote innervation of bioengineered teeth.

Kuchler-Bopp S, Bagnard D, Van-Der-Heyden M, Idoux-Gillet Y, Strub M, Gegout H, Lesot H, Benkirane-Jessel N, Keller L.

J Tissue Eng Regen Med. 2018 Apr;12(4):e2151-e2161. doi: 10.1002/term.2648. Epub 2018 Mar 25.

PMID:
29430872
5.

Current drug design to target the Semaphorin/Neuropilin/Plexin complexes.

Meyer LA, Fritz J, Pierdant-Mancera M, Bagnard D.

Cell Adh Migr. 2016 Nov;10(6):700-708. Review.

6.

Analysis of Semaphorin-Induced Growth Cone Collapse and Axon Growth Inhibition.

Meyer LA, Kaselis A, Satkauskas S, Bagnard D.

Methods Mol Biol. 2017;1493:171-183.

PMID:
27787850
7.

Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide.

Jacob L, Sawma P, Garnier N, Meyer LA, Fritz J, Hussenet T, Spenlé C, Goetz J, Vermot J, Fernandez A, Baumlin N, Aci-Sèche S, Orend G, Roussel G, Crémel G, Genest M, Hubert P, Bagnard D.

Oncotarget. 2016 Sep 6;7(36):57851-57865. doi: 10.18632/oncotarget.11072.

8.

Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide.

Arpel A, Gamper C, Spenlé C, Fernandez A, Jacob L, Baumlin N, Laquerriere P, Orend G, Crémel G, Bagnard D.

Oncotarget. 2016 Aug 23;7(34):54723-54732. doi: 10.18632/oncotarget.10101.

9.

Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Zeniou M, Fève M, Mameri S, Dong J, Salomé C, Chen W, El-Habr EA, Bousson F, Sy M, Obszynski J, Boh A, Villa P, Assad Kahn S, Didier B, Bagnard D, Junier MP, Chneiweiss H, Haiech J, Hibert M, Kilhoffer MC.

PLoS One. 2015 Aug 13;10(8):e0134793. doi: 10.1371/journal.pone.0134793. eCollection 2015.

10.

Spiro Diorthoester (SpiDo), a Human Plasma Stable Acid-Sensitive Cleavable Linker for Lysosomal Release.

Leriche G, Nothisen M, Baumlin N, Muller CD, Bagnard D, Remy JS, Jacques SA, Wagner A.

Bioconjug Chem. 2015 Aug 19;26(8):1461-5. doi: 10.1021/acs.bioconjchem.5b00280. Epub 2015 Jul 14.

PMID:
26131605
11.

Amyloid precursor protein at node of Ranvier modulates nodal formation.

Xu DE, Zhang WM, Yang ZZ, Zhu HM, Yan K, Li S, Bagnard D, Dawe GS, Ma QH, Xiao ZC.

Cell Adh Migr. 2014;8(4):396-403. doi: 10.4161/cam.28802.

12.

Evidence for new homotypic and heterotypic interactions between transmembrane helices of proteins involved in receptor tyrosine kinase and neuropilin signaling.

Sawma P, Roth L, Blanchard C, Bagnard D, Crémel G, Bouveret E, Duneau JP, Sturgis JN, Hubert P.

J Mol Biol. 2014 Dec 12;426(24):4099-4111. doi: 10.1016/j.jmb.2014.10.007. Epub 2014 Oct 12.

PMID:
25315821
13.

Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis.

Arpel A, Sawma P, Spenlé C, Fritz J, Meyer L, Garnier N, Velázquez-Quesada I, Hussenet T, Aci-Sèche S, Baumlin N, Genest M, Brasse D, Hubert P, Crémel G, Orend G, Laquerrière P, Bagnard D.

Cell Rep. 2014 Sep 25;8(6):1714-1721. doi: 10.1016/j.celrep.2014.07.044. Epub 2014 Sep 15.

14.

R-type calcium channels are crucial for semaphorin 3A-induced DRG axon growth cone collapse.

Treinys R, Kaselis A, Jover E, Bagnard D, Šatkauskas S.

PLoS One. 2014 Jul 17;9(7):e102357. doi: 10.1371/journal.pone.0102357. eCollection 2014.

15.

Transmembrane recognition of the semaphorin co-receptors neuropilin 1 and plexin A1: coarse-grained simulations.

Aci-Sèche S, Sawma P, Hubert P, Sturgis JN, Bagnard D, Jacob L, Genest M, Garnier N.

PLoS One. 2014 May 23;9(5):e97779. doi: 10.1371/journal.pone.0097779. eCollection 2014.

16.

Abnormal Wnt and PI3Kinase signaling in the malformed intestine of lama5 deficient mice.

Ritié L, Spenlé C, Lacroute J, Bolcato-Bellemin AL, Lefebvre O, Bole-Feysot C, Jost B, Klein A, Arnold C, Kedinger M, Bagnard D, Orend G, Simon-Assmann P.

PLoS One. 2012;7(5):e37710. doi: 10.1371/journal.pone.0037710. Epub 2012 May 30.

17.

Integration of opposing semaphorin guidance cues in cortical axons.

Ruediger T, Zimmer G, Barchmann S, Castellani V, Bagnard D, Bolz J.

Cereb Cortex. 2013 Mar;23(3):604-14. doi: 10.1093/cercor/bhs044. Epub 2012 Feb 24.

PMID:
22368082
18.

Functional role of laminin α1 chain during cerebellum development.

Heng C, Lefebvre O, Klein A, Edwards MM, Simon-Assmann P, Orend G, Bagnard D.

Cell Adh Migr. 2011 Nov-Dec;5(6):480-9. doi: 10.4161/cam.5.6.19191.

19.

The vesicular SNARE Synaptobrevin is required for Semaphorin 3A axonal repulsion.

Zylbersztejn K, Petkovic M, Burgo A, Deck M, Garel S, Marcos S, Bloch-Gallego E, Nothias F, Serini G, Bagnard D, Binz T, Galli T.

J Cell Biol. 2012 Jan 9;196(1):37-46. doi: 10.1083/jcb.201106113. Epub 2012 Jan 2.

20.

A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, Birmpas C, Katsoris P, Beyrath J, Albanese P, Maurer M, Carpentier G, Strub JM, Van Dorsselaer A, Muller S, Bagnard D, Briand JP, Courty J.

Cancer Res. 2011 May 1;71(9):3296-305. doi: 10.1158/0008-5472.CAN-10-3459. Epub 2011 Mar 17.

Supplemental Content

Loading ...
Support Center